Loading song details...
Alexander Perl MD Discusses The Importance Of Sustained Inhibition When Selecting A FLT3 Inhibitor
No description available.
MP3 Download
Video Download
Related Songs
4:04
Dr Alexander Perl M D Associate Professor Of Medicine At The University Pennsylvania
1:07:54
Management Of FLT3 Positive AML With Dr Alexander Perl
1:23
Alexander Perl MD Discusses CPX 351 Vyxeos Mechanism Of Action And Why It Is A Promising Agent
1:44
Dr Perl On Evolving Treatment In AML
1:59
Alexander Perl MD Discusses Treatment Options For AML Patients
0:53
Alexander Perl MD Discusses The Quantum First Study And Potential Implications
1:25
Alexander Perl MD On Importance Of FLT3 And Provides His Perspective Inhibitor Differences
7:36
Alexander Perl EHA 2019 The Phase III ADMIRAL Trial
1:40
Alexander Perl MD Discusses Treatment Options For Patients With FLT3 ITD Positive AML
0:58
Alexander Perl MD Discusses The Importance Of Sustained Inhibition When Selecting A FLT3 Inhibitor
0:59
Alexander Perl MD Discusses How Molecular Testing Can Facilitate Decision Making In AML Patients
1:58:51
Acute Myeloid Leukemia Part 5 Of Our 6 ASH 2024 Friday Satellite Symposia Series
1:01
Alexander Perl MD On How The BEAT AML Master Trial Will Change Way Patients Are Treated
1:17
Alexander Perl MD On The Role Of Immunotherapy In Treating Hematological Malignancies
0:54
Alexander Perl MD Discusses Abstract 7008 Results And Crenolanib Potential Activity
1:14
Alexander Perl MD Discusses The Potential Impact Of Potency When Selecting A FLT3 Inhibitor
0:41
Alexander Perl MD On The Toxicity In Phase 3 Study Evaluating CPX 351 Vyxeos
2:10
Alexander Perl MD On Prognosis Diagnosis And Treatment Strategies For AML
6:22
EHA 2019 Alexander Perl
1:58:51